MedTrace Logo

Weekly Vitamin D in Pediatric IBD

NCT02076750 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2014-11-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether weekly dosing of oral vitamin D3 is effective in correcting low vitamin D levels in children and adolescents with inflammatory bowel disease (also known as Crohn's disease and ulcerative colitis).

Conditions

  • Inflammatory Bowel Diseases
  • Skin Pigmentation

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 (cholecalciferol)

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Subra Kugathasan, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-03-31
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02076750 on ClinicalTrials.gov